---

**From:** Jill Shannon <avilahector@example.com>  
**Sent:** Monday, October 9, 2023, 9:15 AM  
**To:** Joanna Avila <odomana@example.com>  
**Subject:** Collaboration on the Historical Drug Development Project

Hi Joanna,

I hope this email finds you well. I'm reaching out to discuss our upcoming Historical Drug Development Project. As you know, my team is tasked with conducting a detailed analysis of the evolution of our key pharmaceutical products over the last few decades, particularly focusing on those that have significantly impacted the market.

Given your expertise in investment banking and operational strategies, I believe your insights into the financial trajectory and market impact during the various phases of these drugs could be invaluable. I would love to set up a meeting to explore potential collaboration points. Are you available for a call this Thursday at 3 PM? If not, please let me know your availability.

Additionally, I wanted to mention that I'll be on leave the week of October 23rd, so it would be great to get the ball rolling before then.

Looking forward to your thoughts.

Best regards,

Jill Shannon  
Archaeologist  
Merck & Co.  
avilahector@example.com  
(555) 123-4567

---

**From:** Joanna Avila <odomana@example.com>  
**Sent:** Monday, October 9, 2023, 11:30 AM  
**To:** Jill Shannon <avilahector@example.com>  
**Subject:** Re: Collaboration on the Historical Drug Development Project

Hi Jill,

Thank you for reaching out. The Historical Drug Development Project sounds fascinating, and I agree that understanding the financial and market dynamics could provide a comprehensive view of our products' journeys. I can see how a detailed financial analysis can complement your archaeological insights.

Thursday at 3 PM works perfectly for me. Let’s plan to meet in the conference room on the 5th floor, or we can do a video call if that is more convenient for you. Please let me know your preference.

I’ll bring some preliminary data on market trends and financial outcomes for our flagship products over the last 20 years. This should give us a solid foundation for our discussion.

Looking forward to collaborating with you on this exciting project.

Best,  
Joanna Avila  
Investment Banker, Operational  
Merck & Co.  
odomana@example.com  
(555) 987-6543

---